Sir David Philip Lane received the “Debrecen Award for Molecular Medicine” award by the Faculty of Medicine of the University of Debrecen on Thursday.
The discovery of the British scientist is a step forward in the healing of leukemia.
In every year, the scientific award is given to an internationally recognized researcher, who has been outstanding in the field of life sciences.
From the scientific awards of the University of Debrecen, this one is the most decisive; it recognizes such a scientific work, that is remarkable worldwide. In many cases, the relationship between the university and the awarded scientist becomes the basis of a future cooperation. – said László Csernoch at the press conference that was held before the ceremony.
The “Debrecen Award for Molecular Medicine” has earned international recognition in the last 16 years. The members of the Faculty of Medicine select the awarded scientist by a secret ballot. Considering the ballot, the most important factor is that the chosen scientist must have scientific researches and results that could help thousands or even millions of patients.
This year, Professor Sir David Philip Lane was awarded by the Faculty of Medicine, who has made a breakthrough in cancer research.
Sir David Philip Lane is a British immunologist, molecular biologist and cancer researcher. He is currently Chief Scientist of the Agency for Science, Technology and Research (A*STAR) in Singapore, Scientific Director of Ludwig Cancer Research and Chairman of Chugai Pharmabody. He is best known for the discovery of p53, one of the most important tumor suppressor genes.
Sir David Philip Lane appreciated the Debrecen Award as a great honor.
Source and photos: unideb.hu
